Yf-Vaxの世界市場レポート 2025年：疫学、パイプライン分析、市場インサイトと予測

Yf-Vaxの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8％で91億2,000万米ドルに成長します。この予測期間における成長は、新興国におけるワクチン接種需要の増大、ワクチン流通チャネルの進歩、政府主催のワクチン接種プログラム、ワクチン流通インフラの継続的な進歩、ワクチン製剤と入手可能性の改善などに起因しています。予測期間における主要動向には、製品承認、パートナーシップ、黄色ワクチンの開発などがあります。

媒介性疾患に対する意識の高まりは、Yf-Vax市場の拡大を促進すると予想されます。媒介性疾患は、蚊、ダニ、ノミなどの感染節足動物に刺されることで人や動物に広がる感染症で、ウイルス、細菌、寄生虫などの病原体を媒介し、マラリア、デング熱、ライム病などの病気を引き起こします。これらの病気の流行が増加している背景には、気候変動、都市化、世界の旅行の増加、蚊の個体数の増加などがあり、その結果、より頻繁に発生するようになっています。Yf-Vaxは、免疫系を刺激して抗体を産生させ、感染した蚊が媒介するウイルスから長期にわたって身を守ることで、媒介感染症である黄熱病の予防に役立ちます。例えば、2024年3月、世界動物保健機関は、2023～2024年3月までに28カ国で2,422件の媒介感染症の発生を報告し、欧州では697件の発生がありました。媒介性疾患に対する意識の高まりがYf-Vax市場の成長に寄与しています。

ヘルスケア支出の増加がYf-Vax市場の成長を牽引すると予想されます。高齢化、医療技術の進歩、慢性疾患の蔓延、ヘルスケアサービスに対する需要の高まりといった要因が、ヘルスケア支出の増加に寄与しています。Yf-Vaxは、黄熱病の重症化を予防することで、治療、入院、アウトブレイク管理に関連する費用を削減し、ヘルスケアコストの削減に貢献します。例えば、2024年5月、英国の国家統計局は、2022～2023年にかけて医療費が5.6％増加したと報告した（2022年の伸びは0.9％）。2023年の英国のヘルスケア支出は3,176億3,000万米ドル（2,920億英ポンド）に達しました。その結果、ヘルスケア支出の増加がYf-Vax市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 バイオ医薬品市場における製品特性

• 分子タイプ
• 投与経路（ROA）
• 作用機序（MOA）
• 安全性と有効性

第4章 市場動向と戦略

第5章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第6章 世界の成長分析と戦略分析フレームワーク

• 世界のYf-Vax：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のYf-Vax市場：成長率分析
• 世界のYf-Vax市場の実績：規模と成長、2019～2024年
• 世界のYf-Vax市場の予測：規模と成長、2024～2029年、2034年
• 世界のYf-Vax：総潜在市場規模（TAM）

第7章 世界市場の価格分析と予測

第8章 市場セグメンテーション

• 世界のYf-Vax市場：ワクチンタイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 生弱毒化ワクチン
• 分割投与ワクチン
• 世界のYf-Vax市場：感染タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 森林黄熱病
• 中間型黄熱病
• 都市型黄熱病
• 世界のYf-Vax市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 小売薬局
• 政府の健康プログラム
• 世界のYf-Vax市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 成人
• 高齢者
• 小児

第9章 臨床適応症の世界市場疫学

• 薬剤の副作用
• 臨床適応症の発症率と有病率

第10章 地域別・国別分析

• 世界のYf-Vax市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のYf-Vax市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第11章 アジア太平洋市場

第12章 中国市場

第13章 インド市場

第14章 日本市場

第15章 オーストラリア市場

第16章 韓国市場

第17章 西欧市場

第18章 英国市場

第19章 ドイツ市場

第20章 フランス市場

第21章 東欧市場

第22章 北米市場

第23章 米国市場

第24章 カナダ市場

第25章 南米市場

第26章 中東市場

第27章 アフリカ市場

第28章 競合情勢と企業プロファイル

• Yf-Vax市場：競合情勢
• Yf-Vax市場：企業プロファイル
  • Sanofi S.A.

第29章 世界市場：パイプライン分析

第30章 世界の市場競合ベンチマーキングとダッシュボード

第31章 主要な合併と買収

第32章 最近の市場動向

第33章 市場の潜在力が高い国、戦略

• Yf-Vax市場、2029年：新たな機会を提供する国
• Yf-Vax市場、2029年：新たな機会を提供するセグメント
• Yf-Vax市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第34章 付録

YF-Vax is a live-attenuated vaccine developed to offer long-term protection against yellow fever, a serious viral illness transmitted by infected mosquitoes. It is frequently recommended for travelers and residents in areas where the disease is endemic.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary forms of YF-Vax include live-attenuated vaccines and fractional dose vaccines. Live-attenuated vaccines consist of weakened, yet live, versions of the virus or bacteria responsible for the disease. The disease can be transmitted through different types: sylvatic yellow fever, intermediate yellow fever, and urban yellow fever. These vaccines are available through multiple distribution channels, such as hospitals, retail pharmacies, and government health programs, and are used by various age groups, including adults, the elderly, and children.

The Yf-Vax market research report is one of a series of new reports from The Business Research Company that provides Yf-Vax market statistics, including Yf-Vax industry global market size, regional shares, competitors with a Yf-Vax market share, detailed Yf-Vax market segments, market trends, and opportunities, and any further data you may need to thrive in the Yf-Vax industry. This Yf-Vax market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The Yf-Vax market size is expected to see strong growth in the next few years. It will grow to $9,120 million in 2029 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to growing demand for vaccination in emerging economies and advancements in vaccine distribution channels, government-sponsored vaccination programs, ongoing advancements in vaccine distribution infrastructure, and improvements in vaccine formulations and availability. Major trends in the forecast period include product approvals, partnerships and developments in yellow vaccine.

The growing awareness of vector-borne diseases is expected to drive the expansion of the yf-vax market. Vector-borne diseases are infectious conditions spread to humans and animals through the bites of infected arthropods, such as mosquitoes, ticks, and fleas, which carry pathogens like viruses, bacteria, or parasites, leading to illnesses such as malaria, dengue, and Lyme disease. The rise in the prevalence of these diseases is attributed to factors like climate change, urbanization, increased global travel, and the expansion of mosquito populations, resulting in more frequent outbreaks. YF-Vax helps prevent yellow fever, a vector-borne disease, by stimulating the immune system to produce antibodies that provide long-lasting protection against the virus spread by infected mosquitoes. For example, in March 2024, the World Organization for Animal Health reported 2,422 outbreaks of vector-borne diseases across 28 countries from 2023 to March 2024, with Europe experiencing 697 outbreaks. As awareness of vector-borne diseases rises, it is contributing to the growth of the yf-vax market.

The increasing healthcare spending is expected to drive the yf-vax market's growth. Factors such as an aging population, advancements in medical technology, the growing prevalence of chronic diseases, and higher demand for healthcare services are contributing to rising healthcare expenditures. YF-VAX helps reduce healthcare costs by preventing severe yellow fever infections, which lowers expenses associated with treatment, hospitalizations, and outbreak management. For instance, in May 2024, the Office for National Statistics in the UK reported that healthcare spending grew by 5.6% from 2022 to 2023, compared to 0.9% growth in 2022. The UK's healthcare expenditure amounted to $317.63 billion (£292 billion) in 2023. Consequently, the rise in healthcare spending is fostering the growth of the yf-vax market.

A notable trend in the yf-vax market is the adoption of strategic partnerships to enhance technological integration and expand market presence. Strategic partnerships involve collaborations between organizations, where they combine resources, expertise, and efforts to achieve mutual goals. For example, in March 2022, the International Finance Corporation (IFC), a US-based financial services company, partnered with Institut Pasteur de Dakar (IPD), a Senegal-based yellow fever vaccine manufacturer, to establish a vaccine manufacturing facility in Senegal. The $222 million project, financed through a combination of public, private, and grant funding, will significantly boost IPD's production capacity, initially focusing on COVID-19 vaccines, with plans to expand to other vaccines. Once fully operational, the facility aims to produce up to 300 million doses annually for Africa.

Major players operating in the yf-vax market are Sanofi S.A

North America was the largest region in the yf-vax market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in yf-vax report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the yf-vax market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The yf-vax market consists of sales of vaccine syringes, pre-filled injection devices, and immunization kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Yf-Vax Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on yf-vax market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for yf-vax ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The yf-vax market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Vaccine Type: Live Attenuated Vaccines; Fractional Dose Vaccine
• 2) By Transmission Type: Sylvatic Yellow Fever; Intermediate Yellow Fever; Urban Yellow Fever
• 3) By Distribution Channel: Hospitals; Retail Pharmacies; Government Health Programs
• 4) By End User: Adult; Geriatric; Pediatric
• Companies Mentioned: Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Yf-Vax Market Characteristics

3. Yf-Vax Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Yf-Vax Market Trends And Strategies

5. Yf-Vax Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Yf-Vax Growth Analysis And Strategic Analysis Framework

• 6.1. Global Yf-Vax PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Yf-Vax Market Growth Rate Analysis
• 6.4. Global Yf-Vax Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Yf-Vax Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Yf-Vax Total Addressable Market (TAM)

7. Global Yf-Vax Market Pricing Analysis & Forecasts

8. Yf-Vax Market Segmentation

• 8.1. Global Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Attenuated Vaccines
• Fractional Dose Vaccines
• 8.2. Global Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sylvatic Yellow Fever
• Intermediate Yellow Fever
• Urban Yellow Fever
• 8.3. Global Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Retail Pharmacies
• Government Health Programs
• 8.4. Global Yf-Vax Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adult
• Geriatric
• Pediatric

9. Global Yf-Vax Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Yf-Vax Market Regional And Country Analysis

• 10.1. Global Yf-Vax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Yf-Vax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Yf-Vax Market

• 11.1. Asia-Pacific Yf-Vax Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Yf-Vax Market

• 12.1. China Yf-Vax Market Overview
• 12.2. China Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Yf-Vax Market

• 13.1. India Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Yf-Vax Market

• 14.1. Japan Yf-Vax Market Overview
• 14.2. Japan Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Yf-Vax Market

• 15.1. Australia Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Yf-Vax Market

• 16.1. South Korea Yf-Vax Market Overview
• 16.2. South Korea Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Yf-Vax Market

• 17.1. Western Europe Yf-Vax Market Overview
• 17.2. Western Europe Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Yf-Vax Market

• 18.1. UK Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Yf-Vax Market

• 19.1. Germany Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Yf-Vax Market

• 20.1. France Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Yf-Vax Market

• 21.1. Eastern Europe Yf-Vax Market Overview
• 21.2. Eastern Europe Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Yf-Vax Market

• 22.1. North America Yf-Vax Market Overview
• 22.2. North America Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Yf-Vax Market

• 23.1. USA Yf-Vax Market Overview
• 23.2. USA Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Yf-Vax Market

• 24.1. Canada Yf-Vax Market Overview
• 24.2. Canada Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Yf-Vax Market

• 25.1. South America Yf-Vax Market Overview
• 25.2. South America Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Yf-Vax Market

• 26.1. Middle East Yf-Vax Market Overview
• 26.2. Middle East Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Yf-Vax Market

• 27.1. Africa Yf-Vax Market Overview
• 27.2. Africa Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Yf-Vax Market Competitive Landscape And Company Profiles

• 28.1. Yf-Vax Market Competitive Landscape
• 28.2. Yf-Vax Market Company Profiles
  • 28.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

29. Global Yf-Vax Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Yf-Vax Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Yf-Vax Market

32. Recent Developments In The Yf-Vax Market

33. Yf-Vax Market High Potential Countries, Segments and Strategies

• 33.1 Yf-Vax Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Yf-Vax Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Yf-Vax Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer